TAK — Takeda Pharma Co Ltd Sp ADR

Ownership history in Corient IA LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Corient IA LLC reported a position in Takeda Pharma Co Ltd Sp ADR (TAK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.42% (2025 Q1)
Avg. % of fund
0.32%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 14,880 -10,120 -40.5% 0.22% $232K $15.59
2025 Q3 REDUCED 25,000 -15,000 -37.5% 0.27% $366K $14.64
2025 Q2 UNCHANGED 40,000 — 0% 0.36% $618K $15.46
2025 Q1 INITIATED 40,000 — — 0.42% $595K $14.87
% of Fund (quarterly)    TAK price (monthly, adj. close)

Other funds also holding TAK

As of 2025 Q4 — sorted by position size

MANAGED ASSET PORTFOLIOS, LLC 3Y 7Y 2.82% Clean Yield Group 3Y 7Y 1.13% Legacy Wealth Asset Management, LLC 3Y 0.64% Gold Investment Management Ltd. 0.54% BRANDES INVESTMENT PARTNERS, LP 3Y 7Y 0.46% Carrera Capital Advisors 0.42% Keenan, LLC 0.25% Arjuna Capital 3Y 7Y 0.23% Murphy, Middleton, Hinkle & Parker, Inc. 3Y 7Y 0.23% Larry Mathis Financial Planning, LLC 0.2%
← Back to Corient IA LLC Holdings